Skip to main content

Advertisement

Log in

Primär biliäre Cholangitis

Ursodeoxycholsäure plus Bezafibrat bei PBC

  • journal club
  • Published:
Gastro-News Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

1

Literatur

  1. Lammers WJ et al. Ann Hepatol 2014;13(4):316–26

    PubMed  Google Scholar 

  2. Carbone M et al. Gastroenterology 2013;144(3):560–9 e7; quiz e13–4

    Article  CAS  Google Scholar 

  3. Lammers WJ. Gastroenterology 2014;147(6):1338–49 e5; quiz e15

    Article  CAS  Google Scholar 

  4. Corpechot C et al. J Hepatol 2011;55(6):1361–7

    Article  CAS  Google Scholar 

  5. EASL. J Hepatol 2017;67(1):145–72

    Article  Google Scholar 

  6. Nevens F et al.. Engl J Med 2016;375(7):631–43

    Article  CAS  Google Scholar 

Literatur

  • Corpechot et al. A placebo-controlled trial of Bezafibrate in primary biliary cholangitis. N Engl J Med 2018;378(23): 2171–81

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jassin Rashidi Alavijeh.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alavijeh, J.R., Wedemeyer, H. Ursodeoxycholsäure plus Bezafibrat bei PBC. Gastro-News 5, 11–12 (2018). https://doi.org/10.1007/s15036-018-0441-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15036-018-0441-z

Navigation